Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Endocrinology
|
July 30, 2010
STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone
Jian-Zhong Tang, Xiang-Jun Kong, Arindam Banerjee, et al.
Soft Matter
|
September 13, 2022
Amino acid containing amphiphilic hydrogelators with antibacterial and antiparasitic activities
Biplab Mondal, Vivek Kumar Gupta, Biswanath Hansda, et al.
Cancer Research
|
September 29, 2012
Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells
Pengxu Qian, Arindam Banerjee, Zheng-Sheng Wu, et al.
Translational Oncology
|
August 7, 2010
Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24
Vijay Pandey, Yewon Jung, Jian Kang, et al.
Carcinogenesis
|
January 23, 2019
Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
Arindam Banerjee, Charles N Birts, Matthew Darley, et al.
Oncotarget
|
November 2, 2017
Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
Qing-Yun Chong, Ming-Liang You, Vijay Pandey, et al.
Science Signaling
|
May 7, 2020
p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulators
Charles N Birts, Arindam Banerjee, Matthew Darley, et al.
Oncotarget
|
May 26, 2018
The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells
Arindam Banerjee, Pardis Arvinrad, Matthew Darley, et al.
Cancer Research
|
April 19, 2023
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
Srinivas Reddy Boreddy, Reshmi Nair, Prashant Kumar Pandey, et al.
Cell Death & Disease
|
June 5, 2026
DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer
Wanpei Cai, Sebastian Öther-Gee Pohl, Xianning Lai, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Endocrinology
|
July 30, 2010
STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone
Jian-Zhong Tang, Xiang-Jun Kong, Arindam Banerjee, et al.
Soft Matter
|
September 13, 2022
Amino acid containing amphiphilic hydrogelators with antibacterial and antiparasitic activities
Biplab Mondal, Vivek Kumar Gupta, Biswanath Hansda, et al.
Cancer Research
|
September 29, 2012
Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells
Pengxu Qian, Arindam Banerjee, Zheng-Sheng Wu, et al.
Translational Oncology
|
August 7, 2010
Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24
Vijay Pandey, Yewon Jung, Jian Kang, et al.
Carcinogenesis
|
January 23, 2019
Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
Arindam Banerjee, Charles N Birts, Matthew Darley, et al.
Oncotarget
|
November 2, 2017
Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
Qing-Yun Chong, Ming-Liang You, Vijay Pandey, et al.
Science Signaling
|
May 7, 2020
p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulators
Charles N Birts, Arindam Banerjee, Matthew Darley, et al.
Oncotarget
|
May 26, 2018
The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells
Arindam Banerjee, Pardis Arvinrad, Matthew Darley, et al.
Cancer Research
|
April 19, 2023
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
Srinivas Reddy Boreddy, Reshmi Nair, Prashant Kumar Pandey, et al.
Cell Death & Disease
|
June 5, 2026
DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer
Wanpei Cai, Sebastian Öther-Gee Pohl, Xianning Lai, et al.
Page
of 15